Sharechat Logo

Daily ShareChat: Fisher and Paykel Healthcare

By Jenny Ruth

Tuesday 29th June 2010

Text too small?
 Jenny Ruth

Fisher & Paykel Healthcare is a high quality company with substantial growth opportunities, says Craigs Investment Partners.

“On the basis of our forecasts, which assume the group can continue to deliver on its ambitious medium growth plans, the stock offers valuation appeal, trading at a 20% discount (when trading at $3.16) to our DCF (discounted cashflow)-derived intrinsic value estimate,” the broker says.

It expects new product launches will mean the company's core businesses will continue to grow strongly.

Its respiratory and acute care division will continue to leverage its technological expertise in respiratory humidification to move into associated market segments, progressively widening its addressable market.

Craigs says Fisher & Paykel's management estimates as new products currently under development are launched, the company's addressable market will potentially quadruple.

“This opportunity, coupled with underlying market growth driven by favourable demographic trends, underpins management's 15% medium term volume growth assumption.”

Its new ICON range of flow generators used to treat obstructive sleep apnea should lead to accelerated growth in the second half of 2011, Craigs says.

Craigs is assuming 15% volume growth from that division also, in line with management guidance. While, as an exporter, the company is exposed to exchange rate movements, it is substantially hedged for its 2011 financial year, the broker says.

Recommendation: Buy.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL PILLOWS MASK AT INVESTOR DAY
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins